Skip to main content
SpringerLink
Log in

Tecfidera to be reimbursed for MS patients in British Columbia

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Biogen Idec. British Columbia to Reimburse TECFIDERA(Tm), a First-Line Oral Treatment for Multiple Sclerosis. Media Release : 25 Jun 2014

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tecfidera to be reimbursed for MS patients in British Columbia. PharmacoEcon Outcomes News 706, 16 (2014). https://doi.org/10.1007/s40274-014-1373-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1373-2

Search

Navigation